KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Repurchased

Daily Values

Growth Metrics

Others

Arcosa (ACA) Asset Writedowns and Impairment (2018 - 2025)

Arcosa's Asset Writedowns and Impairment history spans 3 years, with the latest figure at -$400000.0 for Q4 2025.

On a quarterly basis, Asset Writedowns and Impairment changed N/A to -$400000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 million, a 72.41% decrease, with the full-year FY2025 number at $1.6 million, down 72.41% from a year prior.
Asset Writedowns and Impairment hit -$400000.0 in Q4 2025 for Arcosa, down from $2.0 million in the prior quarter.
Over the last five years, Asset Writedowns and Impairment for ACA hit a ceiling of $5.8 million in Q2 2024 and a floor of -$400000.0 in Q4 2025.